IMPORTANCE Nasal continuous positive airway pressure (nCPAP) is a well-established treatment of respiratory distress syndrome in preterm infants. Suboptimal weaning from nCPAP may be associated with lung injury, pulmonary morbidity, and infant weight gain. To our knowledge, the best weaning strategy from nCPAP is unknown.
N asal continuous positive airway pressure (nCPAP) is a widely used treatment of respiratory distress syndrome in preterm infants. [1] [2] [3] [4] [5] [6] [7] [8] [9] Nasal continuous positive airway pressure prevents alveolar collapse, reduces the work of breathing, prevents apneas of prematurity, and prevents lung injury. 4, 5, 10 However, nCPAP is also associated with gastric distension, 11 nasal septum necrosis, 12 and pneumothorax. 6 The benefits and risks of nCPAP are well described, but the optimal strategy for nCPAP weaning remains to be determined. 13 Optimal nCPAP weaning is of great clinical importance because too early weaning from nCPAP and repeated weaning attempts may eventually cause lung injury. Repetitive attempts to wean the preterm infant from nCPAP may cause cycles of atelectasis that are followed by the need for alveolar recruitment, which can damage the alveoli (atelectrauma), increase pulmonary morbidity, and cause chronic lung damage. 10, 14 Pulmonary morbidity causes prolonged oxygen therapy, a prolonged length of stay in the neonatal intensive care unit (NICU), 15, 16 and has been shown to be independently associated with impaired growth (ie, decreased weight gain velocity from birth to discharge from the NICU in preterm infants). 17, 18 Lung injuries on the basis of inappropriate nCPAP weaning with atelectrauma could be one of the most important and potentially preventable elements of lung injury in very preterm infants. Three main weaning methods have been described: graded time off wean, sudden wean, and pressure wean. 13, 19, 20 Graded time off wean has been shown to prolong nCPAP and oxygen duration and increase the risk of bronchopulmonary dysplasia (BPD) and the length of hospital stay compared with either sudden wean or pressure wean. [21] [22] [23] [24] [25] However, it is unknown whether sudden wean or pressure wean is the optimal weaning strategy. The primary aim of this study was to compare the effect of sudden wean and pressure wean from nCPAP on weight gain velocity in very preterm infants. Several secondary outcomes related to measures of growth, weaning attempts, nCPAP, and oxygen therapy were also studied.
Methods
This randomized clinical trial (RCT) was conducted in 6 NICUs in the Central and North Regions of Denmark between September 2012 and December 2016. The Central Denmark Region committees on research ethics approved the protocol and written informed consent was obtained from the parents of every study infant. The trial was registered at Clinical Trials (ClinicalTrials.gov) as NCT01721629, and the trial protocol is in Supplement 1. Further details are in Supplement 2.
Participants
All infants born before 32 weeks of gestation who required nCPAP for more than 24 hours were assessed for eligibility. To be randomized. the infant had to fulfill all the following inclusion criteria: a current postmenstrual age (PMA) of 29 weeks and 0 days or older, nCPAP of 24 hours or more, nCPAP pressure of less than 8 cm H 2 O, an oxygen requirement of less than 30% and not increasing, a respiratory rate of less than 70 breaths per minute, less than 3 episodes of bradycardias (<70 beats/minute) or desaturations (<70%) in the preceding 24 hours, and tolerate time off nCPAP during nursing procedures (up to 15 minutes).
Infants were ineligible if they had undergone gastrointestinal surgery, had known or suspected congenital neuromuscular disease, or had chromosomal anomalies or congenital malformations of the heart, lung, or gastrointestinal tract. Furthermore, infants of parents who were unable to speak or read Danish were considered ineligible.
Randomization
A computer-generated web-based randomization program with a random allocation sequence and log-on procedure that was specific to each center was developed by an independent statistician. This program prompted a systematic assessment of the eligibility criteria, provided a unique randomization number, and assigned the infant or the twin pair to the nCPAP weaning method in a 1:1 ratio. The attending physicians had responsibility for enrolling participants.
The randomization was stratified by study center and gestational age (<28 or 28-32 weeks) and balanced within randomly sized blocks of 2 to 4 to 6 infants in each center. Twins were randomized to the same weaning strategy. Masking to treatment allocation was impossible.
Interventions
According to the Danish National Guideline, very preterm infants were stabilized on nCPAP immediately after birth if possible. If surfactantwasneededtheintubationsurfactantextubationprocedure was used. 26, 27 Infants that failed this procedure and needed mechanical ventilation were always extubated to nCPAP when ready. Weaning from nCPAP was initiated as per the randomization allocation, when the infant met the inclusion criteria, which also served as readiness criteria for weaning from nCPAP.
Sudden Wean Group
In the sudden wean group, nCPAP was discontinued without prior reduction in nCPAP pressure. If the infant failed the discontinuation of the nCPAP, according to the failure criteria, nCPAP was recommenced (eFigure in Supplement 3). A minimum of 1 of the following failure criteria had to be met: persistent tachypnea (respiratory rate ≥ 70 breaths per minute),
Key Points
Question Are there differences between sudden wean and pressure wean from nasal continuous positive airway pressure (nCPAP) in very preterm infants with respect to early growth and respiratory support needs?
Findings In this randomized clinical trial, preterm infants were randomized to sudden vs pressure nCPAP wean and there were no differences found in growth and respiratory support. More infants born before 28 weeks with pressure wean were weaned successfully during the first attempt.
Meaning Overall, in very preterm infants, sudden wean and pressure nCPAP wean are equally good choices when early growth and respiratory support are considered; in infants born before 28 weeks, pressure wean may be preferred.
increased work of breathing (intercostal retractions), an increased oxygen requirement of more than 10% to maintain oxygen saturations or more than 90%, more than 3 episodes of bradycardias (<70 beats per minute) or desaturations (<70%) in the preceding 24 hours, major apnea or bradycardia that required positive pressure ventilation, and a transcutaneous carbon dioxide increase of more than 2.0 kPa from the starting point (if measured). A new attempt of sudden wean was at the earliest made 24 hours from the latest attempt and only when the readiness criteria were met again (eFigure in Supplement 3).
Pressure Wean Group
In the pressure wean group, the nCPAP pressure was decreased by 1 cm H 2 O every 24 hours until a pressure of 4 cm H 2 O was achieved. Then the nCPAP was discontinued. If any of the failure criteria (previously mentioned) were met during the pressure reduction, the nCPAP pressure was increased. If any of the failure criteria were met after discontinuation, nCPAP was recommenced. In both scenarios, a new attempt of pressure wean was at the earliest made 24 hours from the latest attempt and only when the readiness criteria were met again (eFigure in Supplement 3). In the sudden wean and pressure wean groups, a successful wean was defined as no need for recommencing nCPAP according to failure criteria for 3 days after nCPAP discontinuation (eFigure in Supplement 3).
Primary Outcome
The primary outcome was total infant weight gain from randomization to a PMA of 40 weeks divided by the weight at randomization and the number of days from randomization to 40 weeks PMA (ie, weight gain velocity [in grams/kilograms/ day]). The weight was measured by digital baby scales.
Secondary Outcomes
The secondary prespecified outcomes were weight (in grams) at 40 weeks PMA, weight gain velocity (in grams/kilograms/ day) measured from the date of randomization to the date of a successful wean, weight at successful wean (in grams), total days in nCPAP after randomization to a PMA of 40 weeks, PMA at successful wean, a successful wean during the first attempt defined as the ability to stay off nCPAP for 3 days without meeting any failure criteria after the first discontinuation of nCPAP, days to a successful wean measured from the date of randomization to the date of a successful wean, the number of attempts to discontinue nCPAP, supplemental oxygen after randomization to a PMA of 40 weeks (yes/no), days with supplemental oxygen after randomization to a PMA of 40 weeks, BPD defined as the need for supplemental oxygen at a PMA of 36 weeks, a need for supplemental oxygen at discharge from the NICU, length of stay in the NICU, and PMA at discharge.
Sample Size
We estimated the sample size on the basis of prior knowledge on weight gain velocity in preterm infants, 28 taking into account clustering by twinning. 29, 30 We aimed to be able to show a difference in weight gain velocity of 2.5 g/kg/day between the 2 groups. For this difference to be detected with a power of 80% and a 2-sided significance level of P = .05, a total of at least 92 infants in each group had to be recruited. However, anticipating an average cluster size of 2 and an intracluster correlation coefficient of 0.35, the adjusted sample size was 125 infants in each group. To allow for a loss to follow-up and a lack of compliance of 15%, the size of the study population was estimated to be 150 infants in each group.
Statistical Analysis
All analyses were carried out as strict intention-to-treat analyses. Per protocol analyses were performed to examine the robustness of the primary estimates. Analyses were adjusted for the center and clusters of siblings of twin pairs. Clinical characteristics of infants in the 2 nCPAP weaning groups were presented as means with standard deviations for continuous, normally distributed variables, as medians and interquartile ranges (IQRs) for continuous non-normally distributed variables, and as numbers and percentages for categorical variables.
The associations between the interventions and the continuous outcomes were analyzed using a random-effects mixed model regression to account for clustering within the twin pairs who were included in the study. The analyses were also adjusted for the study center. The adjusted mean differences were presented with 95% confidence intervals. The association between the interventions and the dichotomous outcomes were analyzed using a generalized linear model for the binomial family accounting for clustering and adjusted for the study center (the binreg command). The results of these analyses were presented as risk differences with 95% confidence intervals. Furthermore, we performed prespecified subgroup analyses by gestational age. All analyses were conducted using Stata, version 13 (StataCorp).
Results

Study Population
Of the 611 infants born who were before 32 weeks of gestation and admitted to 1 of the 6 participating NICUs between September 2012 and December 2016, 428 infants (70.0%) were eligible and 372 infants (60.9%) were randomized. A total of 354 infants had adequate data for the analysis of the primary outcome ( Figure) . The clinical characteristics were similar in the 2 groups ( Table 1) .
Primary and Secondary Outcomes
There was no statistical significant difference in mean (SD) weight gain velocity from the date of randomization to a PMA of 40 weeks between the sudden wean and pressure wean group (22 [6] g/kg/day in both groups) ( Table 2 ). There was no statistical significant difference between the sudden wean and pressure wean group in any of the secondary outcomes ( Table 2) . A per protocol analysis of the 171 infants in the sudden wean group and the 173 infants in the pressure wean group who followed the protocol showed similar results (eTable in Supplement 3).
Subgroup Analyses
A total of 58 infants (16%) were born with a gestational age younger than 28 weeks and 296 infants (84%) were born with a gestational age between 28 and 31 weeks and 6 days ( Table 3) .
Infants Born Before 28 Weeks of Gestation
In this subgroup of extremely preterm infants, there was no statistical significant difference between the sudden wean and the pressure wean group in mean (SD) weight gain velocity from the date of randomization to a PMA of 40 weeks (19 [6] g/kg/day vs 19 [8] g/kg/day).
Furthermore, there was no difference between sudden wean and pressure wean in any of the secondary outcomes except for successful wean during the first attempt, in which significantly more infants in the pressure wean group were successfully weaned during the first attempt (41% vs 11%; risk difference, 31%; 95% CI, 13%-50%) compared with the sudden wean group (Table 3) .
Infants Born Between 28 and 31 Weeks and 6 Days of Gestation
In this subgroup of very preterm infants there was also no statistical significant difference between the sudden wean and pressure wean group in mean (SD) weight gain velocity from the date of randomization to a PMA of 40 weeks (23 [6] g/kg/day vs 23 [5] g/kg/day). There was no difference in any of the secondary outcomes ( Table 4) .
nCPAP Weaning-Associated Adverse Events
In the pressure wean group 1 infant received a diagnosis of nasal septum necrosis. No other adverse events were observed.
Discussion
We performed this randomized clinical trial to help resolve the uncertainty of how to optimally wean infants born before 32 weeks of gestation from nCPAP. To our knowledge, this is the largest RCT to date on nCPAP weaning, and we found no difference between sudden wean and pressure wean with respect to weight gain velocity, nCPAP and oxygen duration, length of stay in the NICU, or any of the other secondary outcomes that were all related to growth and respiratory support. In the analysis that was stratified by gestational age, more infants who were born before 28 weeks of gestation were successfully weaned from nCPAP during the first attempt in the pressure wean group compared with the sudden wean group without any effect on the secondary outcomes, including the total duration of nCPAP or supplementary oxygen treatment.
The results of this study agree with findings of what to our knowledge is the only other RCT that compares sudden wean and pressure wean in very preterm infants. This study, by Amatya et al, 31 had a sample size of 68 infants born between 26 to 32 weeks of gestation and used successful wean during 53 (30) 54 ( (8) 13 (7) >3 13 (7) 14 ( a Apgar score at 1 minute was unknown for 4 infants (2%) in the sudden wean group and 7 infants (4%) in the pressure wean group.
b Apgar score at 5 minute was unknown for 4 infants (2%) in the sudden wean group and 7 infants (4%) in the pressure wean group.
c nCPAP pressure unknown for 7 infants (4%) in the sudden wean group and 1 infant (0.6%) in the pressure wean group. (7) 21 (8) a Weight gain from randomization to successful wean was unknown for 3 infants (11%) in the sudden wean group.
b Weight at successful wean was unknown for 3 infants (11%) in the sudden wean group.
c Total days in nCPAP after randomization was unknown for 1 infant (4%) in the sudden wean group and 2 infants (7%) in the pressure wean group.
d PMA at successful wean was unknown for 2 infants (7%) in the sudden wean group.
e Successful wean during the first attempt was unknown for 1 infant (4%) in the sudden wean group and 3 infants (10%) in the pressure wean group.
f Number of attempts to discontinue nCPAP was unknown for 1 infant (4%) in the sudden wean group and 2 infants (7%) in the pressure wean group.
g Days to successful wean was unknown for 2 infants in the sudden wean group.
h Based only on infants who were treated with supplemental oxygen. a Weight gain from randomization to successful wean was unknown for 8 infants (5%) in the sudden wean group and 4 infants (2%) in the pressure wean group.
b Weight at successful wean was unknown for 8 infants (5%) in the sudden wean group and 4 infants (2%) in the pressure wean group.
c Total days in nCPAP after randomization was unknown for 2 infants (1%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
d PMA at successful wean was unknown for 5 infants (3%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
e Successful wean during the first attempt was unknown for 2 infants (1%) in the sudden wean group and 6 infants (3%) in the pressure wean group.
f Number of attempts to discontinue nCPAP was unknown for 2 infants (1%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
g Days to successful wean was unknown for 5 infants (3%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
h Days with supplemental oxygen after randomization only included data from the 50 infants (28%) in the sudden wean group and the 44 infants (25%) in the pressure wean group with supplemental oxygen need after randomization.
the first attempt as a primary outcome. They also found no difference between sudden wean and pressure wean in markers of pulmonary morbidity; weight gain, nCPAP and oxygen duration, BPD, and the length of hospital stay. Pressure wean was associated with a higher rate of successful wean during the first attempt compared with sudden wean. This differs from our results, in which the higher rate of successful weans during the first attempt only applied to infants who were born before 28 weeks of gestation. The study by Amatya et al 31 was not powered to perform a stratified analysis. A successful wean during the first attempt is an outcome that is highly dependent on the readiness and failure criteria used, in particular nCPAP pressure. The decision on when to wean preterm infants from nCPAP has limited evidence. 19, [21] [22] [23] 31 We used modified inclusion and failure criteria from the RCT by Todd et al. 21 Because4cmH 2 O was not used in our NICUs before the study, none of the infants were thought to be treated with this pressure at the time of inclusion. However, 4 infants were. They were all born after 28 weeks gestation. The results remained essentially unchanged after excluding those infants in secondary analyses. The finding of a higher rate of successful weans during the first attempt in infants born before 28 weeks of gestation in the pressure wean group could indicate that our criteria may not be entirely appropriate for sudden wean in this subgroup of infants, because more infants in the sudden wean group had to recommence nCPAP. In the pressure wean group, the nCPAP was only discontinued if the infant had demonstrated that the gradual reduction in nCPAP pressure was tolerated; otherwise the nCPAP pressure was increased, indicating that the infants tolerated nCPAP discontinuation. Thus, if, for example, a lower nCPAP pressure was chosen as a readiness criterion for discontinuation, the number of infants weaned during the first attempt would probably have been higher in the sudden wean group.
We used weight gain velocity as a surrogate measure of the associated long-term health outcomes, neurodevelopment and pulmonary morbidity. 18, 28, [32] [33] [34] [35] Inappropriate weaning from nCPAP may cause atelectasis, increased work of breathing, and episodes of desaturation and bradycardia, and animal studies have shown intermittent hypoxic episodes to suppress growth hormone and decrease postnatal weight gain. 36-38 A decreased weight gain velocity was therefore considered a biologically meaningful measure of inappropriate nCPAP weaning. Previous randomized clinical trials of nCPAP weaning used either a successful wean during the first attempt or duration of nCPAP treatment as primary outcomes. [21] [22] [23] [24] [25] 31 However, these outcomes may be influenced by the study design. Thus, the risk of self-fulfilling results would exist if, for example, nCPAP pressures prompting the first wean after randomization were too high for any infant to cease nCPAP during the first a Weight gain from randomization to successful wean was unknown for 5 infants (3%) in the sudden wean group and 4 infants (3%) in the pressure wean group.
b Weight at successful wean was unknown for 5 infants (3%) in the sudden wean group and 4 infants (3%) in the pressure wean group.
c Total days in nCPAP after randomization was unknown for 1 infant (0.7%) in the sudden wean group.
d PMA at successful wean was unknown for 3 infants (2%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
e Successful wean during the first attempt was unknown for 1 infants (0.7%) in the sudden wean group and 3 infants (2%) in the pressure wean group.
f Number of attempts to discontinue nCPAP was unknown for 1 infant (0.7%) in the sudden wean group.
g Days to successful wean was unknown for 3 infants (2%) in the sudden wean group and 2 infants (1%) in the pressure wean group.
h Based only on infants who received supplemental oxygen after randomization. attempt of sudden wean, while infants may still cease during the first attempt by pressure wean. In fact, we had no infants who were randomized to sudden wean that ceased nCPAP at first attempt if enrolled at the upper limit of nCPAP pressure for participation. Thus, a successful wean during the first attempt is an outcome that depends on the readiness and failure criteria used. Days in nCPAP may also be influenced by the study design. The fact that nCPAP pressure had to be gradually reduced by 1 cm H 2 O per day could contribute to an inherently longer duration of therapy in infants who were randomized to a gradual wean in studies with a low nCPAP pressure at inclusion. Therefore, we opted to present both a successful wean during the first attempt and nCPAP duration as secondary outcomes.
Sudden vs Pressure Wean From Nasal Continuous Positive Airway Pressure in Infants Born Before 32 Weeks of Gestation
Limitations
We were unable to mask the health care clinicians to the intervention. However, the possible effect on outcome was decreased by the use of strict criteria for weaning, and the weaning orders that were given by the tending physician at morning rounds rather than the bedside nurse. Furthermore, the randomization sequence was only known by the independent developer of the web-based randomization program, and the health care clinicians had no means of predicting the particular nCPAP weaning strategy for a particular infant, thus securing allocation concealment. The loss to follow-up was modest and there were similar dropout rates in the groups. Furthermore, no apparent pattern in clinical characteristics distinguished infants with no primary outcomes at a PMA of 40 weeks of gestation from those who had. The results that were related to secondary outcomes were similar regardless of whether infants with missing primary outcome information were included in the analyses. Therefore, it seems unlikely that bias on this account could affect the validity of the results.
The presence of multiple gestations in the study population may violate the assumptions of the most commonly used statistical methods. 30 To account for this potential correlation between twins and potential false-positive findings, we used cluster analyses. 30 However, taking clustering into account in the analyses revealed essentially no change in the results. We used inclusion criteria that allowed for the participation of most of the infants who were born before 32 weeks of gestation, including infants who were born from multiple gestations and for whom only a few exclusion criteria applied, which may increase the generalizability of our results to most very preterm infants treated with nCPAP.
Conclusions
Based on the findings in this RCT, sudden wean and pressure wean from nCPAP could be considered equally good weaning strategies from nCPAP with respect to weight gain velocity and several other measures of growth and respiratory support. Pressure wean may be preferred in infants who are born before 28 weeks of gestation, as they had a higher rate of successful weans during the first attempt. A review was performed in 2011 (26) to determine the risks and benefits of different strategies used for the withdrawal of CPAP in preterm infants. Randomized controlled trials and some nonrandomized trials were considered. Three eligible studies were included. The conclusion was that infants who have their CPAP pressure weaned to a predefined level and then stop CPAP therapy completely have less total time on CPAP and shorter durations of oxygen therapy and hospital stay compared with those that have CPAP removed for a predetermined number of hours each day.
Furthermore research concerning ventilation therapy gives rise to suspect that the cycle of recruitment and atelectasis may lead to damage of the lungs, and hence more BPD (27) . The aim of this study is to investigate two different strategies for the withdrawal of CPAP in preterm infants born before 32 weeks of gestation. In a randomized controlled trial the strategy with weaning CPAP pressure to a predefined level and then stop the CPAP therapy completely will be compared to a strategy called sudden wean where the infant is taken off the CPAP therapy and stays without CPAP unless certain specific failure criteria are met. Both strategies will primarily be compared considering the infant's weight at a gestational age of 40 completed weeks; secondary outcomes will be the weight gain during CPAP therapy, the duration of oxygen therapy and length of stay in the NICU.
In the future it is essential that weaning of CPAP in preterm infants is guided by evidence.
Therefore this study is of great clinical relevance. It is important that the CPAP therapy is not prolonged since risks, primarily nasal septum necrosis, are linked to the duration of the therapy (28) (29) (30) (31) (32) . The relationship between the mother and child may be influenced for example the handling of the infant and breastfeeding. Furthermore, CPAP therapy requires constant observation involving both equipment and specially trained personal which are expensive.
Method Study design
A randomized controlled multicenter trial.
Study population
All live born infants born before 32 weeks of gestation and admitted to the NICU's at Aarhus The randomization and stratification on gestational age and site of admission is via an online webbased server. The program is designed with alternating block size of 2-4-6 in random. Twins are randomized to the same treatment. The attending physician or nurse register the infant on the online web-based server and it is determined in which arm the infant is treated. Infants excluded from the study are registered along with the cause for exclusion.
The pressure weaning group
The reduction of the CPAP pressure begins at the morning ward round and the pressure is reduced in steps with 1 cmH2O maximum once a day. Each time the pressure is to be reduced the infant needs to be evaluated according to the inclusion criteria and only if these are still met, will the pressure be reduced. In case the reduction in pressure fails by the criteria mentioned below and the child meets the failure criteria the infant either stays on the same pressure or the pressure is increased, whichever is deemed appropriate by the medical staff. The infant is then treated with the "new" CPAP pressure for the remaining of the day before another attempt of pressure weaning is undertaken. When a CPAP pressure at 4 cmH2O is reached the infant is treated with this pressure for 24 hours and then the CPAP is discontinued. Infants are considered successfully weaned if they are off CPAP for three days.
The sudden wean group
The CPAP is taken off at the morning ward round. If the discontinuation of the CPAP fails, according to the failure criteria, CPAP is recommenced and continued at least 24 hours. Then a new evaluation takes place and if the infant again meets the inclusion criteria another attempt of sudden weans can be undertaken. Infants are considered successfully weaned if they are off CPAP for three days.
Failure criteria
Minimum one of the following criteria needs to be met: 
Statistics
All primary analyses will be analyzed as intention to treat. In addition several per protocol analyses will be performed. The weight gain will be assessed as a continuous variable and the analyses based on linear regression.
The size of the study population is determined based on a power calculation in STATA (statistical software) with the following assumptions:
We want to demonstrate a difference in weight gain of 5 g/kg/day between the two intervention groups. We assume an average weight of 2500 g when the CPAP therapy is successfully weaned and a standard deviation of 200 g, both of which are based on experience from the NICU. With these assumptions we compare an average 2550 g (95% PI (prediction interval): 2158-2942) with 6 2480 g (95% PI: 2088-2872). To achieve a power of 80% by this comparison, 129 infants must be included in each intervention group.
Based on experiences from comparable studies in our unit we assume a participation rate of 85%
and the size of the study population must be 300 infants.
Science Ethical Review
The study does not pose an increased risk or disadvantaged for the infant. No additional blood tests or examinations will be performed. Blood tests are only taken as part of the usual observation and treatment of the preterm infant.
The parents can at any time withdraw their informed consent with no impact on the treatment or follow up of the infant.
This study will contribute to determining the best approach to CPAP weaning with maximal benefits of treatment for the infant and point out the best way to potentially reduce the number of complications to the CPAP therapy and costs and inconvenience to the parents. The study involves all pediatric departments in the Central and North Denmark Region and all necessary equipment and support are available.
